Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Chronic Lower Back Pain Market?
The market size of chronic lower back pain has experienced consistent escalation in the past few years. Expecting to surge from $7.72 billion in 2024 to $8.04 billion in 2025, the market’s compound annual growth rate (CAGR) stands at around 4.1%. The growth during the historic period can be ascribed to idle lifestyles, physical work, professional hazards, advancements in medical diagnosis, evolving pain management techniques, and epidemiological research.
The market for chronic lower back pain is projected to witness consistent expansion in the ensuing years, achieving a value of $9.63 billion by 2029 with a compound annual growth rate (CAGR) of 4.6%. This predicted surge during the forecast timeframe can be credited to a number of factors such as increased non-pharmacological interventions, advance in preventive healthcare measures, emphasis on comprehensive treatments, the advent of regenerative medicine, and aging demographics. The forecast period is also expected to highlight predominant trends such as a greater focus on non-pharmacological interventions, a shift in pain management strategies, enhanced healthcare cognizance and education, use of telemedicine and remote monitoring, and inclusion of regenerative medicine.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp
What Are The Primary Factors Supporting The Chronic Lower Back Pain Market Expansion?
The chronic lower back pain market is predicted to expand due to an expected rise in the occurrence of nerve instances. Nerve instances are specific instances where an individual shows courage, bravery, or persistence when faced with difficult or intimidating circumstances. Persistent exposure to stress and pain can lead to a phenomenon known as central sensitization, where the nervous system becomes extremely sensitive, experiencing pain more intensely even if there’s no actual injury. For example, in July 2023, as reported by Nature, a UK scientific journal that is published weekly, the rate of peripheral neuropathy, which correlates to nerve damage, stood at 28.4% in adults aged 40 or over with diabetes and 11.8% in those without diabetes. Thus, the rise in the frequency of nerve instances is a major factor propelling the growth of the chronic lower back pain market.
Which Segments Define The Structure Of The Chronic Lower Back Pain Market?
The chronic lower back painmarket covered in this report is segmented –
1) By Type Of Pain: Diskogenic Pain; Lumbar Spinal Stenosis; Sacroiliac Pain; Facet-Joint Pain; Radicular Pain; Muscular Pain; Other Types Of Pain
2) By Diagnosis: Clinical History; Physical Examination; Imaging Guidelines; Assessment Of Pain
3) By End-User: Hospitals; Orthopedic Clinics; Ambulatory Surgery Centers; Other End-Users
Subsegments:
1) By Diskogenic Pain: Herniated Disc; Degenerative Disc Disease; Disc Bulge; Lumbar Spinal Stenosis
2) By Lumbar Spinal Stenosis: Central Stenosis; Lateral Stenosis
3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction; Inflammatory Conditions
4) By Facet-Joint Pain: Facet Joint Syndrome; Osteoarthritis Of The Facet Joints
5) By Radicular Pain: Sciatica; Nerve Root Compression
6) By Muscular Pain: Muscle Strain; Muscle Spasm
7) By Other Types of Pain: Myofascial Pain Syndrome; Spondylolisthesis; Osteoporosis-Related Pain
Which Long-Term Trends Will Play A Crucial Role In The Chronic Lower Back Pain Market?
Significant players in the chronic lower back pain market are prioritizing the creation of groundbreaking pharmaceuticals to serve their clientele and maintain their market standing. The invention of novel drugs can enhance treatment results for people suffering from various ailments. For instance, Amneal Pharmaceuticals, an American pharmaceutical corporation, unveiled LYVISPAH, a FDA-approved baclofen oral granule (5, 10, and 20 mg), in July 2022. The drug is designed to tackle spasticity associated with multiple sclerosis and other spinal cord disorders. LYVISPAH is effective in managing and alleviating flexor spasms and related pain, clones, and muscular rigidity. The medication offers a customizable dosage with single-dose granule packets available in doses of 5 mg, 10 mg, and 20 mg and is equivalent to oral baclofen tablets. LYVISPAH could significantly improve the quality of life for patients suffering from spinal cord injuries and other related diseases.
Who Are The Primary Market Leaders In The Chronic Lower Back Pain Market?
Major companies operating in the chronic lower back pain market include Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy’s Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report
What Regional Factors Are Accelerating Growth In The Chronic Lower Back Pain Market?
North America was the largest region in the chronic lower back pain market in 2024. The regions covered in the chronic lower back pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=9946&type=smp
Browse Through More Reports Similar to the Global Chronic Lower Back Pain Market 2025, By The Business Research Company
Iot In Manufacturing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report
Power Generators Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/power-generators-global-market-report
Ventricular Assist Device Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model